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Biomedical research comprises one of the most important t and well-funded areas in all of 
scientific research. Technological innovation is a relatively small component of all research 
overall, but the applications are of immense benefit.  Incorporation of already existing technologies 
from other areas of research directly into a biomedical setting is a simple way to leverage human 
innovation into the highest applicability. 
Vibrational spectroscopy is one such technology which, while steadily seeing more and 
more use in biomedical imaging, is still underutilized.  Such advanced microspectroscopic 
techniques can leverage their ability to analyze global information in a cellular system to higher 
throughput and increased efficiencies. 
Metabolism is a key global system for every cell type and organism.  Energy production, 
metabolic pathway augmentation, metabolite analysis, and appraisal of overall metabolic poise are 
several ways in which characterization of metabolism can be used analytically. Each of these can 
provide valuable insights into cellular systems and associated conditions, namely illness and 
disease.   
Using Raman spectroscopy to characterize metabolism has led to several interesting 
results.  First, analysis of drug candidacy has shown a novel mode for drug testing.  Effectively 
evaluating cellular health based on several different techniques shows level compatibility across 




mitochondrial protection conferral.  In a similar vein of research, targeted analysis of desiccation 
tolerant proteins, localized to mitochondria, likewise showed a protective mechanism.  Finally, an 
analysis of substrate change directly on metabolism was carefully evaluated, with an outcome of 
visualizing effects of varying metabolic pathways upon overall global cellular metabolism.  
These studies provide a strong platform for spectrometabolic evaluation to be considered 
for a variety of advanced characterization techniques. Coupling this method with other emerging 







Chapter 1  
Introduction 
 
The investment in biomedical research is the highest across all research and development 
sectors.  Worldwide, this amounts to approximately $133 billion per year. (Grassano, 2020) The 
United States federal government, via the National Institute of Health, appropriates approximately 
$41.7 billion into this research, generally with increased allocation year-to-year. (Public Law 116-
94, 2020) Domestic industry spends nearly $40 billion to this end. (Stewart, 2015) The 
development of a single drug from idea to market ranges from $314 million to $2.8 billion, the 
average cost being $985 million. (Wouters, 2020) Perhaps the most significant factor which 
contributes to the enormous costs of pharmaceuticals to market is the U.S. Food and Drug 
Administration approval process, which rejects some 86.2% of initial filings. (Wong, 2019) Even 
small improvements to research method optimization can decrease real costs tremendously. 
Incorporating advanced techniques to achieve improved efficiency of research, both in 
terms of cost and time investment, is therefore a particularly desirable goal. By bridging traditional 
methods, which have widespread use and degree of confidence, with modern techniques, which 
have more attractive and useful features, a new paradigm of improved research techniques can be 
established.  There are, of course, many different techniques which can be employed to bring about 




Vibrational spectroscopy is a technique which uses intrinsic characteristics to supply global 
molecular information.  The two primary forms of vibrational spectroscopy are Raman and 
Infrared. This can be used for widespread material analysis, such as the effects of corrosion on 
metals or the distribution of polymers in advanced composites. (Hayez, 2004; Tanaka, 2006) 
However, these techniques show particular utility in a biological setting on a cellular basis. 
(Gremlich, 2000) The unification of multiple traditional techniques into one systemic process 
should create much lower barriers to research where such global analysis would be of particular 
scientific interest.  
One such global system that is universally studied and has profound implications for 
disease, ageing, and performance is metabolism. Metabolism is the totality of all process which 
occur to sustain life processes for a particular organism.  Of principal interest is the biochemistry 
of how the body generates energy for these processes. Some of the most important, though 
certainly not exhaustive, metabolic pathways are oxidative phosphorylation, the electron transport 
chain, glycolysis, pentose phosphate pathway, and fatty acid biosynthesis.  The first two occurring 
inside of the mitochondrial membrane, while the remainder takes place in the cytosol.  Quantifying 
these chemical processes gives direct insight into the bioenergetics, metabolic poise, and potential 
cellular dysfunction. (Dagley, 1970) 
One clear example where metabolism varies drastically is comparing primary cells, which 
are the cells or tissues which a patient or subject would provide, to model tumor derived cell lines, 
which are derived from primary cells that have mutated to grow beyond normal cellular senescence 
and so become immortalized, e.g., HeLa or HepG2 cells. (Scherer, 1953) These cell lines are very 
important to biomedical research due to their relative ease of use, cost effectiveness, and utility in 




display a proclivity for alternate pathways of biosynthetic energy production.  Namely, there is a 
distinct shift in upregulation for glycolytic flux so that substrate level phosphorylation occurs over 
the primary bioenergetic mode of primary cells, which lies in oxidative phosphorylation localized 
to the mitochondria and the associated electron transport chain.  This favoring of glycolysis over 
aerobic respiration is known as the Warburg effect and is seen as a hallmark of most tumor derived 
cells (Warburg, 1956) So, by evaluating global metabolic poise, a cell can be determined whether 
to be of primary origin or tumor derived.   
By being able to monitor metabolism via non-invasive spectroscopy as has been described, 
the individual cell response to targeted therapeutic treatments can be evaluated.  It is possible to 
compartmentalize the cell into its constituent cellular features, such as nucleus, mitochondria, and 
cell membrane, via vibrational spectroscopy and so to see exactly where changes to the treatment 
are occurring.  Furthermore, repetitions of treatments over long periods of time can be viewed per 
the same individual cell, so that statistical averaging of large cell numbers cannot miss intricacies 
inherent on a cell-to-cell basis.  The ability to see a pharmaceuticals impact on metabolism in a 
physiological setting is the basis for developing a therapeutic method which would eventually lead 
to a clinical application.  This would reduce sample waste and increase global cellular information 
availability which would have faster analytical turnarounds.  The method proposed herein has the 
ability to make many therapeutics safer, more reliable, and have broader application. This would, 
in general, promote a more discerning analysis, especially with respect to the predictive appraisal 





Chapter 2  
Characterization of Metabolism 
 
2.1 Metabolism 
Metabolism is fundamental to life in that it comprises all processes which allow an 
organism to function.  Metabolism can be organized into several key purposes as the complexity 
of all biochemical processes is immense. Foremost, it considers the biochemistry associated with 
the conversion of energy sources into biologically available energy.  There exist hundreds of 
metabolic pathways, though generally some are far more efficient and thus more common across 
all organisms. (Smith, 2004) One example being carboxylic acids necessary for the citric acid cycle 
which is found in all known organisms. Similarly, metabolism concerns input fuel being 
catabolized into base building blocks for common biomolecules such as lipids, proteins, and 
nucleic acids.  It must also consider elimination of waste or byproducts of biochemical processes. 
Evaluation of metabolism in humans can be used to detect certain metabolically linked 
diseases, namely type II diabetes, neurodegenerative diseases, and cancers, as normal metabolic 
function is severely impaired.  Furthermore, many drug compounds will have an effect upon 
cellular metabolism, whether intended or not.  They may be specifically designed to alter 
metabolism, (Wilkinson, 2005) but all too often this occurs as a result of unintended toxicity. 
(Gillette, 1974) In humans, this toxicity will predominately occur in the liver, as this organ is 




drugs, or high enough levels of any drug compound, can overwhelm the liver and cause liver failure 
due to intracellular component injury, typically the mitochondria.  Having the ability to 
characterize metabolism as a whole, and on subcellular level of mitochondria can lead to important 
insights into such diseases largely based upon drug-induced toxicity. 
 
2.2 Mitochondria 
Through genomic deduction (Anderson, 2003) and other evidence, (Gray, 2001; Melendez-
Hevia, 1996) it is theorized that modern mitochondrial evolution has its origins possibly 2 billion 
years ago.  Due to the high degree of shared genetic code shared between mitochondria and α-
proteobacteria, it is also surmised that bacteria became endosymbionts for another primitive 
prokaryotic cell type.  This may have been caused due to extreme global events which dramatically 
increased the atmospheric oxygen availability. (Smith, 2018) Since oxygen is a powerful oxidizing 
agent, it acts as a strong toxin for anaerobic organisms.  Therefore, there was an evolutionary 
incentive to incorporate the aerobic-respiration-capable α-proteobacteria. This became a powerful 
feature, in that excess chemical energy in the form of adenosine triphosphate (ATP) was generated.  
It is possible that this eventually led to the rise of not only eukaryotic cells, but all complex 
multicellular life, which reaches into today’s genetics. 
Today, mitochondria are present in nearly all eukaryotic cells, with small exceptions such 
as red blood cells.  An important structural feature to the organelle is that it is bound by a 
phospholipid bilayer, embedded with many proteins called porins. Mitochondria are responsible 
for regulating many metabolic pathways.  In aerobic environments, mitochondrial respiration via 




cell types.  In anaerobic environments, this largely shifts to fermentation, producing lactate.  While 
fermentation has faster rates of ATP production than respiration, the overall net yield of ATP 
favors respiration by 15-to-1 (mol ATP per mol glucose). (Bonora, 2012) There are certain cell 
types which do not display this standard preferred respiration-based metabolism. As previously 
discussed, cancers generally prefer substrate linked phosphorylation, meaning that other pathways, 
such as glycolysis or the pentose phosphate pathway (PPP) are utilized much more, regardless of 
aerobic conditions. (Vander Heiden, 2017) 
Characterizing the metabolites, the biochemical molecules which serve as intermediates 
for metabolic processes such as ATP and ADP (adenosine di-phosphate), has been of immense 
interest to research for decades.  The evaluation of all metabolites in a cellular system is called 
metabolomics and can be used as a basis for metabolism linked research, especially in the novel 
pharmaceuticals field. 
 
2.3 Extracellular Flux Analysis 
Bioenergetic monitoring can be achieved using extracellular flux analysis.  Considered a 
“gold standard”, this is a fluorescent probe technique which quantifies dissolved oxygen and 
proton concentrations in media contained within a transient microchamber.  Both oxygen 
consumption rate (OCR) and extracellular acidification rate (ECAR) measurements are taken with 
respect to time and can be used to generate metabolic profiles, which can define the cellular 
metabolic regime.  The method generally utilizes metabolism-altering reagents to characterize the 




Oligomycin is a F0F1-ATPase inhibitor, (Capaldi, 2002) which causes respiration-linked 
ATP production to cease. Carbonyl-cyanide-4-(trifluoromethoxy) phenylhydrazone (FCCP) acts 
as the uncoupling agent which collapses the mitochondrial proton gradient and so uncouples 
oxidation from phosphorylation, maximizing OCR. Contributions to OCR due to non-
mitochondrial processes is analyzed by applying both rotenone and antimycin A, which inhibit 
complex I and complex III of the mitochondrial membrane respectively, effectively eliminating 
all contributions to OCR via mitochondrial respiration. 
Glucose can be supplied as to fully saturate basal ECAR. As previously stated, since 
oligomycin inhibits ATP synthase, and since the proton production from mitochondrial respiration 
does not then have upstream offset to ECAR, the effect is seen as a maximization of ECAR. 2-DG 
is a glucose analog which competitively inhibits hexokinase, effectively arresting glycolysis and 
so stopping glycolytic-linked change to ECAR.   
 
2.4 Metabolomics 
The Scripps Research Institute hosts a metabolite database containing some 450,000 
entries. (Smith 2005) The Human Metabolome Database displays some 110,000 metabolites on 
record. (https://www.genome.jp/kegg/pathway/map/map01100.html) Of all known reposited 
biomolecules, generally about 300 are considered to be of most common relevance.  Among these, 
only a handful are usually characterized, as these are metabolites directly linked with the most 
commonly used metabolic pathways, i.e., glycolysis, oxidative phosphorylation, PPP. There are 





2.4a Mass Spectroscopy 
Mass spectroscopy (MS) is a widely used analytical technique used in many fields.  It 
possesses a very high degree of detection threshold and can identify virtually all compounds.  
(Sparkman, 2000) These devices consist of an ion source, a mass analyzer, and a detection system. 
They operate on the basis of measuring an ions mass to charge ratio.  A sample enters the ionization 
field, e.g., an electron beam, where it is ionized.  Due to the magnetic field in the analyzer portion, 
there is an induced deflection to the generated ionic particles which corresponds directly to the 
mass to charge ratio, which when processed after collection, can be used to exactly show weight 
distributions of the sample in a spectrum output which can be correlated to known molecules. 
Mass spectroscopy is generally utilized in conjunction with either (high performance) 
liquid chromatography (LC) or gas chromatography (GC).  Both of these chromatography 
techniques are highly effective in separating samples. (Sparkman, 2011) High performance liquid 
chromatography relies on passing a liquid sample in mobile phase through a filtering column filled 
with adsorbent of varying sized particles.  The mass transfer effects of the high-pressure liquid 
sample input causes the sample to interact with the column based on sample particle size.  This 
allows for the sample to be separated very accurately based on size, which increases sensitivity in 
the mass spectrometer.  Gas chromatography is a technique which involves heating samples to 
vaporize, along with using another inert carrier gas to bring the vaporized sample in mobile phase 
to pass through the stationary phase where the sample can be detected through electronic detectors.  
In part, the ability to separate comes from the material properties of the analyte fluid, namely the 
vaporization point and adsorptive properties due to particle size, visualized as retention time. 
Advantages of GC-MS are the very high separation reproducibility, compatibility with 




accommodating to solids and liquids, and extremely high degree of detection sensitivity. However, 
both of these techniques are destructive (the sample is irrecoverable), requires relatively high 
amounts of sample (10-200 µL) and are slow analysis techniques. 
 
2.4b Nuclear Magnetic Resonance Spectroscopy 
Nuclear magnetic resonance (NMR) spectroscopy is a technique which fundamentally 
observes local magnetic fields around NMR-active atomic nuclei (most commonly H1 and C13).  
(Hoult, 1997) It works by inducing, via a magnetic field, a polarization of magnetic nuclear spins.  
The polarization is disturbed by a radio frequency pulse, which generates a weak oscillating 
magnetic field.  The NMR-active nuclei emit electromagnetic waves which are detectable.  NMR 
spectroscopy provides extremely high degrees of detection with unique signatures for a wide range 
of sample types.  Spectral acquisition time increases directly with increase to element weight due 
to increased relaxation times, meaning samples can take minutes to hours to complete.  Therefore, 
it has mixed utility when analyzing biological components, as many organic compounds are out 
of range for efficient scanning.  Furthermore, NMR has very high costs (up to $5 million) and 






Chapter 3  
Raman Spectroscopy 
 
3.1 Raman Scattering Theory 
The chemical bonds between atom pairs can be modeled as a spring between point masses 
following Hook’s Law, which represent a harmonic oscillator with a single resonant vibrational 
frequency. (Sasic, 2011) For molecules containing more than two atoms, normal vibrations occur 
at a total, for a molecule of n atoms, of 3n-5 for linear molecules and 3n-6 for nonlinear molecules.  
It is possible for different vibration modes to occur at the same frequency, and thus overlap.  
Furthermore, parts of molecules which are not coupled vibrationally to the rest of the molecule 
possess nearly the same frequencies of vibration, regardless of what molecules they are attached 
to. For example, a phenyl ring or thiol group will accord to the same vibrational signature no matter 
what it happens to be bound with.  Vibrations are often grouped by the type of motion which occurs 
during oscillation.  Some of these are; when bond length oscillates, it is termed “stretch”, bond 
angle oscillation is termed “bend”, while other specialized oscillations are “rock”, “breathing”, 
and “wag”. 
Raman scattering occurs when a photon has an inelastic collision with a molecule, which 
causes a quantized transfer of energy to the molecule.  Graphing the intensity of the scattered 
photon relative to the energy shift from the incident light (meaning any electromagnetic wave, 




molecule excites the molecule to a virtual state, via an electrical distortion of the chemical bond 
by the lights electric field.  This virtual state does not represent a quantum mechanical stationary 
state but rather an induced dipole moment.  The virtual state instantaneously relaxes back to the 
ground state of the molecule, emitting a photon. If the photon is elastically scattered, whereby the 
same vibrational state is achieved after emission, Rayleigh scattering has occurred. If the photon 
inelastically loses energy, thereby reducing frequency and increasing wavelength, a Raman-Stokes 
shift has occurred. A photon which increases its vibrational energy and so has a decrease in 
wavelength is a Raman-Anti-Stokes shift. 
Based on a quantum mechanical model (Placzek, 1959), an analytic equation can be written 
for Raman intensity; 
 
𝐼𝐼𝑅𝑅 = (𝐼𝐼𝐿𝐿𝜎𝜎𝑅𝑅𝑋𝑋)𝑃𝑃𝑃𝑃 
 
where IR is Raman intensity [photons/sec], IL is the intensity of the laser [photons/sec], σR 
represents absolute Raman cross section [cm2/molecule], X is an experimentally derived constant, 
P is sample path length [cm], and C is concentration [molecules/cm3]. 
This shows several practical considerations for spectral acquisition.  Since Raman intensity 
is proportional to excitation intensity, Raman signal can be improved simply by increasing laser 
power, up until the threshold level where the intensity may damage the analyte.  Lasers are used 
due to the feature of coherence (spatial and temporal), that is, all light is in the same phase; 
monochromatic and collimated. Without this feature, it would be near impossible to analyze the 




analyte, which allows for quantitative analysis. Raman intensity increases with Raman photon 
frequency (to the fourth power) and since Raman photon frequency is directly proportionate to the 
excitation frequency, the Raman intensity greatly increases with increasing energy level 
corresponding to the type of electromagnetic wave. 
 
3.2 Raman Microspectroscopy with Common Techniques 
Coupling a Raman spectrometer to a microscope system has several attractive features.  
The basic schematic of such a system is shown below.  Raman requires very little sample 
preparation due to the nature of the scattering event.  Spectra can be acquired from very small 
sample sizes.  Raman is generally insensitive to water and so can be used where many other 
techniques, including IR spectroscopy, are disadvantaged.  Using pinhole optics, a confocal 
microscopic configuration can be employed, which further allows raster imaging.  This also allows 
for the generation of hyperspectral maps by taking large arrays of individual Raman spectra and 
then comparing a spectral feature based on intensity to map the specific peak position across the 





Figure 3.1: Schematic of Raman spectrometer connected to microscope 
 
Figure 3.1 shows the three primary components of a microspectroscopic system; the 
microscope, the light source, and the spectrometer with detector.  The microscope is coupled, via 




aluminum garnet) laser which is frequency doubled to emit at 532 nm wavelength.  The laser is 
directed though a polarizer and then the microscope objective to the sample where scattering 
occurs from the analyte.  The scattered light is collected with the same objective and travels 
through the microscope, where it is filtered by a notch, line, or long pass filter to eliminate or 
reduce the Rayleigh scattered light.  The light also will travel through a pinhole optic to create the 
confocal configuration.  Upon entering the spectrometer, the light will be expanded and focused 
onto the grating, an optical tool used to differentiate the beam of light based on wavelength due to 
the blazed surface (here either 600 or 1800 lines/mm). The beam is then condensed and strikes the 
detector.  Here, an (EM)CCD is used, an electron multiplied charge couple device. Fundamentally, 
a CCD translates incident photons into electric charges. (Boyle, 1970) This allows the beam of 
wavelength-segregated light to be converted into an electronic based spectrum.  
The quality of spectrum is generally characterized by the noise levels over the actual 
sensitivity, by the signal-to-noise (STN) ratio.  There are many ways to improve this ratio; 
physically, materially, and mathematically.  As previously stated, the laser power can be increased, 
up until damage thresholds are reached.  The sample acquisition/integration time can be increased 
to lower non-Raman spectral contributions.  Multiple accumulations can be acquired, whereby the 
averaging of spectra will cancel statistically random noise.  One of the largest factors to negatively 
impact Raman spectrum output is fluorescence. This can be negated by using a different excitation 
wavelength outside of the fluorophore’s excitation band.  Alternatively, photobleaching techniques 
can be used.  Materially, certain physical effects can be leveraged to produce a higher than nominal 
Raman scattering event probability (which randomly is approximately 1 in 1010 photons).  This 
includes resonance Raman, surface enhanced Raman, and coherent anti-stokes Raman.  Once the 




includes the multivariate statistical methods of principal component analysis and cluster analysis.  
Finally, to separate spectral peaks which happen to overlap, deconvolution methods can be used.  
 
3.2a Surface Enhanced Raman (SERS) 
Surface enhanced Raman spectroscopy can be utilized when an analyte is very close to a 
metal surface. (Stiles, 2008) An electromagnetic enhancement occurs which serves to amplify the 
Raman intensity due to localized surface plasmons.  Surface plasmons occur when an incident 
electrical field displaces the metal conducting electrons, causing an oscillating resonance which 
then has a charge transfer mechanism back to the analyte.  Surface plasmons depend heavily upon 
surface topology.  Smooth and flat surfaces are incapable of producing such an effect.  But rough 
or colloidal metal, or specially nanostructured materials, generally made of silver or gold as these 
resonate with visible light frequencies, can produce increased Raman intensity output by a factor 
of 104 to an enormous 1014 improvement, depending on shape and other surface interaction 
variables. 
 
3.2b Resonance Raman 
Resonance Raman scattering occurs when the excitation radiation’s photon energy level 
matches exactly the electronic absorption band, causing the Raman intensity to increase by as 
much as six orders of magnitude. (Robert, 2009) The falloff in Raman intensity is drastic as the 
resonance frequency is departed from.  Thus, this technique only effectively works when a known 
laser emission wavelength happens to be the proper exciting wavelength for a molecule.  This is 




intensity.  It can also be employed to characterize vibrational modes of a subgroup of molecules 
from a very large molecule, such as a polypeptide. 
 
3.2c Coherent Anti-Stokes Raman (CARS) 
Coherent anti-stokes Raman spectroscopy is a non-spontaneous technique used to increase 
Raman intensity. (Begley, 1974) The technique works by utilizing two laser beams to stimulate 
the analyte.  One laser light (pump field) excites the molecules to an elevated virtual energy state.  
The second laser (Stokes field) scatters the already stimulated photon to an excited vibrational 
energy level.  Light from the pump field excites this elevated vibrational energy state to another 
virtual energy level, before it sinks back to ground state, thereby emitting an anti-Stokes scattered 
photon. 
 
3.3 Signal Processing 
Basic signal processing methods are used to remove unwanted or non-Raman contributions 
from the resultant spectrum output after acquisition.  While shielded from virtually all 
environmental influence, the CCD can still register cosmic rays.  These are some of the most 
energetic particles that move throughout the universe, originating largely from supernovae of 
massive stars.  These are relatively rare and easily subtractable.  Every spectrum has a baseline 
saturation value which has many contributions, including thermal energy to the CCD, which is 
why it is typically stabilized to -60°C.  The method used for baseline subtraction varies from 
sample to sample, usually dependent on if any fluorescence is acquired.  Contributions from matrix 




be removed by collecting pure spectrum of the contributing matrix and calculating a normalized 
subtraction. 
 
3.3a Principal Component Analysis 
Principal component analysis (PCA) is a mathematical technique which ultimately reduces 
the dimensionality of a (generally large) data set. (Wold, 1987) In general, PCA will only apply to 
hyperspectral maps, collected from large areas of a sample, with many spectra in the dataset.  First, 
the data is standardized to z scores. A covariance matrix of p x p dimensions (where p is original 
dimensionality) is created and then reduced to lower triangular form.  From here, eigenvalues and 
eigenvectors are computed and then ranked to determine what the principal components (PC) of 
the new reorganized dataset will be.  Practically, the number of PCs to be included in the 
reconstructed data set is determined by a cutoff STN threshold, where real Raman signal is fully 
retained but noise is removed.  This is because the actual Raman intensity is contained within the 
first few PCs, while the remainder PCs are only noise contributions.  As an example, the original 
dimensionality is determined by the pixels on the CCD detector chip, which is 1600.  PCA reduces 
the dimensionality from 1600 to approximately 10, where the remainder 1590 contain noise.  This 
technique provides the best post processing reduction to noise, while preserving information.  It is 
potentially liable to remove certain real Raman contributions, especially if the original sampled 





3.3b Cluster Analysis 
Cluster analysis is premised on the simple notion of clustering sets of objects from a total 
population into groups based on the relative affinity the objects have to one another. (Edwards, 
1965) How this is of benefit to Raman spectroscopy is in applying the model (here a centroid-
based clustering model) to a hyperspectral image.  The clustering engine will segregate individual 
data members into groups based on closeness to a central vector, generated by the total population 
information, as well as the predetermined number of clusters that are meant to be differentiated 
into.  Practically, this can use a clustering algorithm (there are many) to separate a hyperspectral 
image into its primary features, e.g., for a cell, into the cell and surrounding water/media. 
 
3.3c Deconvolution Analysis 
Spectral deconvolution is the inverse process of convolution.  It is a fundamental method 
used in spectroscopy. (Ayers, 1988) When spectral peaks, which present as Gaussian curves (or 
other normally distributed function), overlap in a single spectrum, as is common in the output from 
the CCD, then deconvolution must be employed to separate individual components from one 
another.  The process by which this is done can be called non-linear iterative curve fitting, whereby 
an initial “best estimate” is made by either manual input or algorithmic recommendation, usually 
on the basis of analytical features such as 2nd derivative analysis of spectrum.  From deconvolution, 
analysis on individual peaks can take place on key properties such as peak intensity, peak position, 





Chapter 4  
Metabolic and Vibrational Spectroscopic Appraisal of the Protective Role of D-512 on 
Induced Neurodegenerative ROS Generation in PC12 Cells 
 
4.1 Introduction 
Parkinson’s disease (PD) is a debilitating neurodegenerative disorder which largely affects 
the elderly population.  Clinically, it is characterized by tremors, bradykinesia, rigidity, and 
postural instability, (Carlsson, 1959; Parkinson 2002) all of which are severe motor function 
impairments which is identic to PD. Principal symptoms are the effects of the loss of particular 
dopaminergic neurons of the substantia nigra pars compacta. (Bertler, 1959; Barbeau 1962) The 
result of this cellular loss being increased iron concentrations, acute changes in oxidative stress 
markers, and accumulation of ‘Lewy bodies’. (Jellinger, 1992; Forno, 1996) Aging, toxicity, and 
mutation only account for 5% of PD cases. (Hornykiewicz, 1989; Langston, 1983; Schapira, 1993; 
Polymeropoulos, 1997; Lesage, 2009) 
Creation of, or inability to detoxify, destructive free radicals and hydrogen peroxide 
(reactive oxygen species; ROS) in critical regions of the brain induce neuropathology of the 
common sporadic form of PD. Mitochondria are the organelles which have the ability to facilitate 
the most ROS generation, at levels upward of 90%. Toxins which inhibit mitochondrial complex 
I, such as rotenone, lead to defects in the electron transport chain (ETC) leading to leaked protons 




vulnerability of dopaminergic neurons implies dopamine (DA) itself as a significant contributing 
factor to the disease genesis and progression. Autooxidation and metabolism of monoamine 
oxidase B can generate 6-hydroxydopamine (6-OHDA) and DA quinones, leading to higher ROS 
generation. (Linert, 2000) 
The creation of a dopamine D2/D3 agonist compound, D-512, has been previously 
reported. (Shah, 2014) It has multi-faceted clinical application, as it acts as antioxidant, iron-
chelator, and neuroprotector. (Li, 2010; Gogoi, 2011; Johnson, 2012) The findings of the initial 
study were shown to inhibit ROS generation in a mammalian neural model and ward against 
disease initiation and progression. 
The metabolic implications and underpinnings of the novel D2/D3 agonists were not fully 
elucidated, however. To monitor the effects of clinically mirrored incubation conditions via 
extracellular flux analysis and Raman spectroscopy has given important insights into the effects 
of the mechanisms of D-512, used in a protective role against 6-OHDA induced ROS generation.  
Results herein show strong support for the use of D-512, as the in vitro cell model showed 





4.2 Materials and Methods 
 
4.2a Cell Culture and Treatments 
Rattus norvegicus adrenal gland pheochromocytoma cells (PC12, ATCC CRL-1721) were 
cultured in T-25 flasks (Thermo Fisher Scientific, Waltham, MA) with RPMI 1640 (Gibco, 
Waltham, MA) medium supplemented with 10% heat-inactivated horse serum (Gibco, Waltham, 
MA), 5% fetal bovine serum (Gibco, Waltham, MA), 100 U/mL penicillin, and 100 ug/mL 
streptomycin in humidified air and 5% CO2. Stock solutions of 6-OHDA, shown in fig. 4.1a, and 
D-512, shown in fig. 4.1b, were prepared in DMSO and aliquots were stored at −20°C and −80°C, 
respectively. The five treatment conditions are diagramed in fig. 4.1c and are as follows: 1) 
untreated cells, 2) 10 µM D-512 for 24 hr, 3) 75 µM 6-OHDA for 24 hr, 4) 10 µM D-512 for 24 
hr followed by 75 µM 6-OHDA for 24 hr (pre-incubation), and 5) 10 µM D-512 for 24 hr followed 





Figure 4.1: Molecular structure of reagents and treatment growth plan - A) Molecular structure of 
hydroxydopamine.  B) Molecular structure of D-512. C) PC12 cells were incubated in five 
different conditions and then returned to normal culture conditions to view growth or else taken to 
extracellular flux or Raman spectroscopic analysis. 
 
4.2b Metabolic Analysis 
An extracellular flux analyzer (XFp Seahorse, Agilent Technologies, Santa Clara, CA) was 
used to characterize metabolic activity of PC12 cells.  All Seahorse XFp consumables were 
purchased from Agilent.  Cells were dissociated from culture flasks using trypsin (Gibco, 
Waltham, MA). The cells were centrifuged at 200 x g for 5 min, the supernatant was removed, and 
the cell pellet resuspended in media. Cell number was enumerated using a 0.04% trypan blue 
exclusion dye (Life technologies, Carlsbad, CA) and a hemocytometer (Hausser Scientific, 




per well. After an initial 24 hr incubation to promote attachment, media was replaced with media 
solutions according to the previous five conditions for appropriate durations. 
Both oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) 
measurements were taken using standard Seahorse protocol, following optimization for cell line. 
Briefly, XFp cartridge sensors were hydrated, and injection ports loaded by the following; 
mitochondrial test reagents used oligomycin (1 μM), carbonyl-cyanide-4-(trifluoromethoxy) 
phenylhydrazone (FCCP, 0.5 μM), and rotenone/antimycin A (0.5 μM). Glycolysis test reagents 
used D-glucose (10 mM), oligomycin (1 μM), and 2-deoxyglucose (2-DG, 50 mM). All reagents 
have corresponding final well concentrations immediately after being listed.  
Oligomycin is a F0F1-ATPase inhibitor, stopping respiration-linked ATP production. 
FCCP acts as an uncoupling agent that collapses the mitochondrial proton gradient and thereby 
uncouples oxidation from phosphorylation, maximizing OCR. The contribution to OCR via non-
mitochondrial processes was measured using rotenone and antimycin A. Rotenone inhibits 
complex I and antimycin A inhibits complex III of the mitochondrial membrane, effectively 
arresting mitochondrial respiration. 
Glucose was supplied as to fully saturate basal ECAR. As previously stated, since 
oligomycin inhibits ATP synthase, proton production from mitochondrial respiration does not 
offset ECAR, having an effect to maximize ECAR. 2-DG is a glucose analog which competitively 





4.2c Measurement of Cell Viability 
One week growth of all conditions was evaluated to determine the effect of D-512 and 6-
OHDA on cell growth. PC12 cells were seeded in T-25 flasks at an initial cell number of 2.5x106 
in triplicate. These cells then had each of the treatment conditions applied for the allotted 
timeframes, shown in fig. 4.1c. After treatment concluded, the media was replaced (without D-512 
or 6-OHDA) and left to culture for a further 24 hr (at which point they are considered to be at day 
1). Cells were collected, as before, on day 1, 3, and 7 for independent flasks, which were grown in 
parallel such that counting would not disrupt further growth.  
 
4.2d Raman Microspectroscopy 
Spatially correlated Raman microspectroscopic measurements were employed to 
characterize living PC12 cell samples at in vitro culture conditions. A customized confocal 
microscope (Zeiss Corp., Germany) and Raman spectrometer combination (UHTS 300, WITec 
Instruments Corp., Germany) was used and the Raman spectra were collected using a sensitive 
CCD camera (Andor Technology, UK) at a spatial resolution of 500 nm. A 532 nm solid state laser 
calibrated to 20 mW was used for excitation and a custom 50X high resolution objective (Mitutoyo, 
Japan). The changes in the spectral signature from the intracellular space were analyzed using a 
hyperspectral molecular analysis technique. Spectral arrays were collected using a spatial 
dimension of 40μm×40μm with a spectral dimension of 80x80 pixels, with N=3. Each array of 
scans was collected using an integration time of 0.5 s. Typical background and substrate 
subtractions were employed, using WITec Project 5 and Peakfit v4 software. Principal component 
analysis (PCA) was used to reduce the dimensionality of the collected spectral data arrays into 




selecting PC number. Following noise reduction using PCA, hierarchal cluster analysis was used 
to construct average spectral signatures for regional components of the cellular hyperspectral 
arrays. Pure samples of 6-OHDA and D-512 were also acquired using point scanning to acquire 
base references for each compound when in solution (Fig. 4.8). 
 
4.2e Statistical Analysis 
Data are expressed as mean value ± standard error mean (SEM), unless otherwise noted. 
For multiple groups, statistical significance was determined using one-way analysis of variance 
(ANOVA). In all cases p ≤ 0.05 was considered as statistically significant. Origin 2018 (OriginLab, 




4.3a Cellular Growth 
Fig. 4.2a shows the normalized growth rates of PC12 cells in five conditions.  Counts were 
performed on days 0, 1, 3, and 7. Initial cell density was equal across all samples at day 0. The 





Figure 4.2: Growth rate comparison of several PC12 conditions - A) Cells were enumerated on 
days 1, 3, and 7. Most notable is the low early growth rate of the pre/co-incubated cells, followed 
by a rapid increase in cell number. B) Ratio of day 7 to day 1 counts, where overall impact of 
conditions is seen. D-512 and pre/co-incubated cells had no difference in growth rate compared to 
untreated cells. Conditions which were exposed to 6-OHDA without D-512 co-incubation had 
significantly lower growth levels than control.  C) Pre/co-incubation cells had interesting growth 
characteristics, and so the growth rate from day 1 to day 3 (X) and from day 3 to day 7 (Y) were 
compared to control. There is a marked increase in growth rate from pre-day 3 to post-day 3. 




Fig. 4.2b displays the ratio of cell number from day 7 to day 1, highlighting one-week total 
growth for all conditions, shown as (mean ± SEM), n=4. Those cells which were grown without 
treatment, labeled control, (5.89 ± 0.41) and those treated with D-512 alone (5.74 ± 0.36) had very 
similar growth rates, higher than other conditions. D-512 cells had a higher initial growth (day 1 
to 3) however. Cells treated with 6-OHDA (3.10 ± 0.40), including those with a pre-treatment of 
D-512 (3.79 ± 0.10), showed relatively poor growth (significance shown in fig. 4.2b).  The cell 
counts were much decreased from day 0 to day 1, possibly indicating certain cells had better 
resistance to 6-OHDA and so did not all immediately perish.  Cells which had D-512 in culture 
when 6-OHDA was applied had initially low growth, similar to the 6-OHDA alone condition, but 
followed by large increase in growth rate to compare to control cells (6.48 ± 0.37).  This is shown 
clearly in fig. 4.2c, where X is the percent ratio of cell increase from day 1 to 3 (50.3%) and Y is 
the increase in day 3 to 7 (218.5%); both with respect to control growth. 
 
4.3b Bioenergetics 
Extracellular flux analysis for OCR, normalized to 106 cells, is shown in fig. 4.3a. Figure 
legend in top right indicates condition for A-D. Control cells have highest normalized basal OCR. 
Both D-512 and pre/co-incubated cells had lower OCRs by one-third fold.  Both cell groups which 
had 6-OHDA incubation had significantly lower basal OCR than control. Oligomycin has the 
anticipated decreasing effect on OCR, across all cell groups. FCCP injection shows much 
increased OCR for control, D-512, and pre/co-incubation, approximately 30% over basal OCR.  
There was little increase for both 6-OHDA groups, indicating some critical injury to mitochondria 




mitochondria number. Rotenone injection inhibits all mitochondrial respiration and is therefore 
used as a zeroing metric. 
 
 
Figure 4.3: Bioenergetic outcomes and metabolic parameters - Results of the extracellular flux 
analysis of incubated conditions for PC12 cells. Metabolic analysis indicates deficiencies in 
mitochondrial parameters for cell incubated in 6-OHDA and cells incubated with a pre-treatment 
of D-512 followed by 6-OHDA alone.  Cells incubated in D512 and those pre-treated and co-
treated with D512 have no significant differences in mitochondrial parameters. *p<0.05, Error 
is +/- SEM, n=3. 
 
Fig. 4.3b similarly shows normalized ECAR for the cell conditions.  Glucose saturation 
yielded similar data for all cell types, with the notable exception of D-512 being increased over 




has similar trends, excepting the large decrease in pre-incubated cells.  It may be explained by 
damage to the mitochondria (as in fig. 4.3a) having a proportionately larger effect on the other 
conditions.  However, this would not clearly explain why the 6-OHDA condition is not affected in 
the same manner. 
Various respiration parameters, described in methods, is shown in fig. 4.3c. Here, 
differences in mitochondrial respiration between the control, D-512, and pre/co-incubation sets 
and the 6-OHDA and pre-incubation sets are apparent even more so.  Maximal respiration, ATP 
production, and spare respiratory capacity all have parity between members of the first group, 
which are significantly greater than the calculated parameters of the 6-OHDA group.  
Fig. 4.3d displays the calculated glycolytic parameters, also described in methods.  Here, 
there is far less apparent differences in conditions than for respiration. There are only significant 
differences in glycolysis for the 6-OHDA against control. There is also a significant drop in 
glycolytic capacity for the 6-OHDA treated cells.  Both cells which had 6-OHDA treatment saw 
significant drops in glycolytic reserve and non-glycolytic acidification. 
 
4.3c Bioenergetically-linked Growth Indices 
Fig. 4.4 compares the growth rate (fig. 4.2b) against four different bioenergetic parameters 
(fig. 4.3). Fig. 4.4a compares to basal respiration.  A linear fit shows a strong correlation (R2>0.95) 
for the conditions.  Pre-incubated and 6-OHDA cells were co-localized at the lower quadrant.  
Pre/co-incubated and control cells were near the highest end of the trend shown here, while the D-





Figure 4.4: Direct comparison of bioenergetic and growth rate of various treatment groups - A) 
Respiration and growth rate have a very strong linear relationship across the five treatment groups. 
B) Spare respiratory capacity has a similar trend to A, with small variation in that control and D-
512 are left shifted, indicating a lower bioenergetic efficiency. C) Glycolysis does not have any 
apparent trend linked to growth rate across all treatments.  The line imposed is of equal slope to A 
to show approximate graph division.  D) Glycolytic reserve has a strong linear relationship to 
growth rate as well.  The apparent increase in slope is largely due to the low reserve levels these 
cells have, as in a basal state operate at high glycolytic modes. Error is +/- SEM, n=3. 
 
Basal glycolysis, shown fig. 4.4b, had similar positions of conditions as fig. 4.4a, but had 
no true linear relationship.  The dashed line is of equal slope to the basal respiration fitted line (fig. 




Fig. 4.4c compares against spare respiratory capacity where control and D-512 conditions 
were co-localized, as were the 6-OHDA and pre-incubated cells. Pre/co-incubated cells were 
notably higher (linearly) over all other conditions.  SRC has the strongest linear relationship among 
all parameters, relative to growth rate. 
Fig. 4.4d shows the glycolytic reserve compared to growth rate. As noted in fig. 4.3d, this 
glycolytic parameter has similarity to the respiration parameters. Glycolytic reserve has a strong 
linear relationship to growth rate as well.  Despite the large error ranges on glycolytic reserve, a 
strong linear correlation is shown. The apparent increase in slope is likely due to the low reserve 
levels these cells have, as in a basal state operate at high glycolytic percentages. 
Fig. 4.5 compares ATP production from oxidative-phosphorylation and glycolysis 
pathways for all cell conditions.  There is a presumption that the angle of the line intersecting the 
control condition and the origin can be used to infer relative disposition to respiration or glycolysis, 
apart from the bioenergetic modes typical of PC12 cells (αPC12=71.5°). Across the spectrum of all 
cells, it may well be that PC12 are intrinsically offset to one metabolic pathway or another, but for 
the subset of only PC12, αPC12 should be used as the baseline. Both D-512 and pre/co-incubation 
conditions are slightly inclined to glycolysis compared to control.  6-OHDA and pre-incubation 





Figure 4.5: Comparison of glycolytic and respiration linked ATP production rates - ATP 
production values normalized to cell number were calculated from extracellular flux data, based 
on equations for respective glycolytic and respiration linked ATP production.  Taking control as a 
metric for PC12 cells normal ATP production ratio, angles and extended lines corresponding to 










4.3d Raman Microspectroscopy 
 
 
Figure 4.6: Raman microspectroscopy of PC12 cells - A) Schematic of Raman spectrometer 
coupled with confocal microscope and laser system. B) A Raman hyperspectral image of a group 
of four PC12 cells. Mitochondrial regions are marked by black outline in cells, confirmed by 750, 
1135, and 1548 rel. 1/cm peaks assigned to cytochrome-c.  Membrane spectra was extracted by 
cluster analysis and is shown as half shaded region at cells periphery. Scale shows increasing 
intensity with respect to maximum 750 rel. 1/cm peak. C) Spectra is total average of area contained 
in marked region for both mitochondria and membrane cellular regions.  
 
The technique for acquiring hyperspectral images (fig. 4.6b) and extracted spectra (fig. 
4.6c) is described in methods. Fig. 4.7a-d shows Raman hyperspectral images generated on the 
CH2 stretching mode (2940 rel. 1/cm) and each image is self-normalized to a scale of 0-1 a.u., 
with scale bar 5 um for all.    Fig. 4.7a is an image of an untreated PC12 cell. Fig. 4.7b is a group 
of three PC12 cells which have been incubated in 10 uM D-512 for 24 hr. Fig. 4.7c shows cells 
which has been incubated with 75 uM 6-OHDA for 24 hr. Fig. 4.7d shows cells which were 
preincubated with 10 uM D-512 for 24 hr followed by coincubation with 75 uM 6-OHDA for a 
further 24 hr.  Using the hyperspectral images in fig. 4.7a-d, fig. 4.7e displays extracted Raman 
spectral intensities of relevance. Spectral positions used were the phenylalanine peak at 1003 rel. 
1/cm, amide I peak at 1650 rel. 1/cm and CH2 stretching peak at 2940 rel. 1/cm. There are several 




rel. 1/cm compared to the spare respiratory capacity of respective incubation conditions.  There is 
no difference between control and pre/co-incubated cells, whereas cells treated with 6-OHDA 






Figure 4.7:  Raman hyperspectral images of various PC12 conditions - Raman hyperspectral 
images generated on the CH2 stretching mode (2940 rel. 1/cm) and each image is self-normalized 
to a scale of 0-1 a.u.   A) Untreated PC12 cell. B) PC12 cells which have been incubated in 10 uM 
D-512 for 24 hr. This image shows three cells in a group. C) Cells which has been incubated with75 
uM 6-OHDA for 24 hr. D) Cells which were preincubated with 10 uM D-512 for 24 hr followed 
by coincubation with 75 uM 6-OHDA for a further 24 hr.  Scale bar is 5 um for all. E) Extracted 
Raman spectral intensities from images seen in A-D.  Spectral positions used were the 
phenylalanine peak at 1003 rel. 1/cm, amide I peak at 1650 rel. 1/cm and CH2 stretching peak at 
2940 rel. 1/cm. F) The spectral intensity of phenylalanine at 1003 rel. 1/cm compared to the spare 
respiratory capacity of respective incubation conditions.  There is no difference between control 






Outgrowth following treatment incubation periods (Fig. 4.2A) shows minimal differences 
between control and D-512 conditions over the full 7-day period. The exception being a marginal 
increase of growth at day 3 for D-512 over control.  6-OHDA and pre-incubation conditions 
similarly show little difference.  This would seem to indicate presence of D-512 by itself has little 
to no effect on overall growth. It may seem surprising that there is any growth at all, but overall 
cell numbers were very low compared to control, however, normalized to day 1 data, it appears 
growth is somewhat comparable (though still quite lower).  This may be explained by certain cells 
having innate resistance or immunity to the neurotoxic effects of the 6-OHDA, though it was 
outside the scope of this study to determine that fully.  The interesting feature of this graph is the 
pre/co-incubation condition. As shown in fig. 4.2C, the growth from day 1 to 3 is similar to that 
of the 6-OHDA group, about half that of control.  However, from day 3 to 7, the growth is 
accelerated to approximately double that of control to ultimately yield an overall growth similar 
to control.  
Bioenergetic data (Fig. 4.3) indicates similar relationships to growth among cell conditions 
such that control and D-512 are distinguished from 6-OHDA and pre-incubated conditions. 
Normalized metabolic parameters indicate that the condition which has comparable performance 
to control is the pre/co-incubated cells. All others groups have diminished metabolic performance 
to varying degrees.  Differences are more apparent in ECAR data than OCR, indicating 
mitochondria are more strongly affected by presence of 6-OHDA, which is where is known to be 
inducing neurotoxic/ROS damages. This data would support that D-512 prevents such damage 
from agents such as 6-OHDA, which induce ROS damages in mitochondria.  Such damages may 




The relationship between metabolism and growth becomes more apparent when directly 
correlated.  Strong linear correlations indicate a clear response to growth from differences in 
metabolism. Lower placement on the curve indicates lower overall cellular health. Deviations 
above the linear curve represent efficient coupling as there is higher growth per same metabolic 
output. Excursions below linear represent inefficiencies likely due to cellular damage and represent 
less growth output per metabolic unit. Some deviations may be minorly affected due to the 
metabolic data being immediately taken after treatment, whereas fold increase in growth is over 7 
days.  As such, differences in immediate and final growth may not correlate exactly. One instance 
of this would be the D-512 condition which would appear to have more efficient coupling than 
other conditions for both respiration and glycolysis comparisons.  Taken for the immediate 
metabolism which, from fig. 4.2A, follows growth trends in that immediate growth is increased 
over control.  Using initial metabolism as a predictor of final growth may prove useful for future 
trials. 
Using established methods, the ATP production from both main metabolic pathways is 
compared for all conditions using slope analysis. Assuming control PC12 cells can be using as a 
reference for standard metabolic pathway ratio, other treatment conditions can be assessed. Pre/co-
incubation has much higher ATP production for both pathways, over all other conditions.  It is 
seen that the two conditions affected by 6-OHDA have severely afflicted mitochondrial function. 
An explanation for the elevated ATP levels for the pre/co-incubated conditions follows previous 
suppositions.  There may be initial injury to the cells, but non-permanent, for which energy 
demands increase greatly to offset ROS/other damages which ultimately result in initially delayed 




Raman hyperspectral imaging allows for high resolution mapping of cellular features.  
Using known markers, mitochondrial regions are determined, and spectral signatures compared.  
The 1003 rel. 1/cm phenylalanine peak is resistant to environmental interference and is a high 
quality quantitative marker for protein content.  Comparing this to the spare respiratory capacity 
derived from bioenergetic analysis, the aptitude of the cells to respond to OCR/ATP/energy 
demands per mitochondrial unit is evaluated.  Supporting previous conclusions, there is no 
statistical difference for control and pre/co-incubated groups while the ratio for 6-OHDA is 
significantly diminished.  Since the phenylalanine peak is insensitive to outside effects, and 
damage/degradation of mitochondria would increase the ratio, a decrease in ratio is largely due to 
a decrease in SRC.  Since lower SRC represents cells operating closer to maximum levels, which 
has previously been posited to accord to higher energy demand and thus likely having been 
introduced to a destructive impetus, i.e., ROS damage.  The ability to use a non-invasive 
spectroscopic technique to validate drug-induced differences in metabolic outcome is an 
invaluable research tool for drug candidate testing. It can serve to promote an analysis regime 
which offers; fast testing times, very low sample requirements, and broad applicability across 
many cell types.  It is even more powerful a tool when databases of normalized cellular 
spectrometabolic data is logged and therefore can be used as a metric for atypical cellular function 










Chapter 5  
Raman Microspectroscopy Indicates Membrane Stabilization as Mechanism for Cell 
Stabilization Conferred by the Group 3 Late Embryogenesis Abundant Protein AfrLEA3m 
 
5.1 Introduction 
A common molecular strategy to survive severe desiccation observed in invertebrate 
animals is to accumulate intrinsically disordered proteins such as late embryogenesis abundant 
(LEA) proteins. (Xu, 1996) Brine shrimp (Artemia franciscana) embryos in desiccation tolerant 
phases are known to expresses several different types of LEA proteins. (Sharon, 2009) Recent 
studies indicate that the different types of LEA proteins may play a critical role in increasing 
stability of different cellular targets including proteins, nucleic acids, and phospholipid bilayers. 
(Tolleter, 2007 & 2010) The current study aims at characterizing the protective benefits of a LEA 
protein derived from brine shrimp. AfrLEA3m is a group 3 LEA protein and expression of the 
protein in mammalian cells have been shown to impart significant desiccation tolerance. In this 
study, a combined confocal Raman microspectroscopic technique and hyperspectral image 
analysis technique was used to characterize the effect of ectopic expression of AfrLEA3m proteins 
in hepatocellular carcinoma cells (HepG2) under highly desiccated condition. The cells were 
desiccated using a fast-spin-drying technique. (Chakraborty, 2011) Detailed Raman spectroscopic 
analysis demonstrates that AfrLEA3m confers protection to cells upon acute desiccation via 
interaction with lipid bilayer. Upon desiccation, the intrinsically disordered proteins form into 




mechanistic protection to the lipid bilayers during acute desiccation, AfrLEA3m may have a 
distinct role to play in protecting cellular mitochondria during desiccation. This was demonstrated 
by bioenergetic evaluation of AfrLEA3m expressing HepG2 cells that were dry-processed and 
recovered to physiological conditions following desiccation. Viability measurements for 
AfrLEA3m cells indicate improved outcomes from dry processing compared to AfrLEA3m free 
cells. 
Successful stabilization of mammalian cells is of high clinical and scientific interest. (Scott, 
2005; Acker, 2005; Taylor, 2006; Fowler, 2006) Preservation in a desiccated state introduces high 
storage efficiencies in comparison to cryopreserved system, whereby the dry stabilized cellular 
system is largely independent from support systems requirements, and long-term stability at room 
temperature simplifies commercial transportation. (Saragusty, 2019) Several anhydrobiotic 
organisms have the ability to survive complete or near complete desiccation (Nakahara, 2010; 
Ricci, 1987), however, owing to their high sensitivity to cellular water content mammalian cells 
are difficult to dry process. Therefore, much focus has been given to biomimetic approaches which 
apply natural strategies identified in anhydrobiotic animals to mammalian systems. (Chakraborty, 
2012; Hand, 2015; Chakrabortee, 2000) Previous studies demonstrated that ectopic expression of 
the late embryogenesis abundant (LEA) protein AfrLEA3m in hepatocellular carcinoma (HepG2) 
cells yielded 93.6% (97.7% if trehalose used in tandem) of viable cells after desiccation to ≤ 0.12g 
H2O/gDW employing a fast-drying technique of spin drying. (Chakraborty, 2012) While that is a 
big step forward in successfully dry processing mammalian cells, the challenges remain in 
successful long-term stabilization of cells in desiccated cells. For that reason, it is important to 
understand the mechanism by which AfrLEA3m confers protection to mammalian cells, which 




interacts in the intracellular space which will improve understanding of the mechanism by which 
AfrLEA3m confers protection during desiccation.   
Understanding the exact mechanism of LEA protein protection holds a special place in 
developing a successful strategy for dry stabilization of mammalian cells. LEA proteins belong to 
the larger group of intrinsically disordered proteins (Shih, 2008; Hunault, 2010) and are known to 
be expressed in desiccation tolerant organisms when desiccated. LEA proteins were first 
discovered in cotton seeds (Dure III, 1981) but have since been discovered in a variety of 
anhydrobiotic organisms in the phyla Arthropoda and Nematoda. In anhydrobiotic organisms, 
LEA proteins have been hypothesized to synergistically work with trehalose to provide protection 
to desiccation stresses. (Iturriaga, 2008) While the mechanism of protection offered by LEA 
proteins to stabilize cells and cellular components is not yet properly understood, several studies 
have indicated potential roles of these unique proteins in preventing protein aggregation (Boucher, 
2010) and stabilization of biological membranes. It has been demonstrated that several LEA 
proteins assume additional secondary structures, such as α helices, β sheets, and hairpin loops 
during desiccation. (LeBlanc, 2019; Shimizu, 2010) 
In the current study a group 3 LEA protein derived from Artemia franciscana, AfrLEA3m 
was used to characterize the nature of desiccation tolerance offered by LEA proteins. AfrLEA3m 
protein has been shown to confer water-stress tolerance in HepG2 cells and is known to be 
synthesized in the cytoplasm and accumulate in the mitochondrial matrix. (Boswell, 2014 & 2014) 
While it is understandable that expression of AfrLEA3m in a mammalian cell may improve 
mitochondrial stability, it was also observed that cells expressing AfrLEA3m also had higher 
membrane integrity following rehydration.  In this study confocal Raman microspectroscopy and 




AfrLEA3m in HepG2 cells in both desiccated and hydrated conditions. Cells were dried uniformly 
to a highly desiccated state (0.2 gH20/gDW) in an inert environment using the fast-drying technique 
of spin drying to limit time duration for osmotic excursions. Trehalose was used in the desiccation 
medium to offer lyoprotection during drying. The confocal Raman microspectroscopy technique 
used here has the advantage of specially determining chemical characteristics in both the 
intracellular and extracellular space. Special attention was given to mitochondria and cellular 
membrane analysis as key indicators of overall health and metabolism. Cell membrane is an 
important injury site while lyoprocessing mammalian cells and this technique was used to compare 
the chemical characteristics of the cellular membranes expressing AfrLEA3m and control cells in 
both hydrated and desiccated conditions. Change in membrane characteristics were also evaluated 
before lyoprocessing and following rehydration. Effect of expression of AfrLEA3m on cellular 
metabolism was also evaluated and compared pre-and post lyoprocessing using spin drying. The 
current study indicates the possibility of group 3 LEA proteins such as AfrLEA3m having a 
protective effect both on cell membrane and mitochondrial function and both of these protective 
effects may originate from its ability to protect the mitochondrial membrane during desiccation. 
 
5.2 Materials and Methods 
 
5.2a Cell Culture 
Human hepatocellular carcinoma (HepG2) cells were stably transfected using a 
tetracycline (Tet)-inducible expression system to express the AfrLEA3m protein, as previously 




was developed by stable transfection with a gene encoding the Tet-transactivator protein. The 
original nucleic acid sequences for AfrLEA3m were cloned from A. franciscana embryos and was 
optimized for human codon bias. The codon optimized nucleic acid construct was next inserted 
into a Tet-On expression vector (pTRE3G) and stably transfected into HepG2 Tet-On cells and 
stable clones were obtained after selection with G418 at 800 µg/mL for 6 weeks. Clones were 
selected for high induction of AfrLEA3m by tetracycline and cultured without induction in Opti-
MEM (Gibco, Carlsbad, CA) supplemented with 5% fetal bovine serum (Gibco) and penicillin-
streptomycin (100 units/mL penicillin G, 100µg/mL streptomycin sulfate; HyClone-Thermo 
Scientific, Logan, UT) under standard cell culture conditions (95% air, 5% CO2, and 37°C).  Cells 
were grown in 75 cm2 cell culture flasks (Corning Incorporated, Corning, NY) and allowed to 
reach a maximum confluency of 90%. Cells were dislodged with 0.05% trypsin centrifuged, and 
counted with a hemocytometer (Hausser Scientific, Horsham, PA) and 0.04% Trypan Blue 
exclusion stain (ThermoFisher, Waltham, MA) to enumerate live cells. 
 
5.2b Acute Desiccation Using Spin Drying 
Cells were plated on collagen coated quartz windows (20 mm Ø, Edmund Optics, 
Barrington, NJ) at a density of 5x104 cells per disc.  After 24 h incubation with 0.5 µM doxycycline 
to induce AfrLEA3m expression, the cells on the quartz windows were spin-dried using a Cee 
200X (Brewer Science, Rolla, MO) as described prior (Chakraborty, 2012)  Briefly, 250 µL of a 
37°C trehalose-based desiccation solution (1.2 M trehalose, 10 mM KCl, 5 mM glucose, 20 mM 
HEPES, 0.5 mM K2HPO4, 0.5 mM KH2PO4, 20 mM glycerol, and 120 mM betaine; pH 7.4) was 




for 55 s, followed by a ramp to 3000 RPM for 5 s.  This was done under an environment of dry 
nitrogen gas. 
 
5.2c Raman Microspectroscopy 
Raman microspectroscopic measurements were carried out with a customized confocal 
microscope and Raman spectrometer combination (UHTS 300, WITec Instruments Corp., 
Germany). Raman spectra were collected using an EMCCD camera (Andor Technology, UK). A 
532 nm solid state laser calibrated to 20 mW was used for excitation and spectra were collected 
using a custom 50X high resolution objective (Mitutoyo, Japan).  Area spectral arrays were 
collected at 250 nm intervals, with an integration time of 0.5 s.  Raman hyperspectral images were 
collected for six conditions in total. Unprocessed cells for both unexpressed and AfrLEA3m 
expressed cells were taken as normal physiological conditions. Spin dried cells were unexpressed 
and AfrLEA3m expressed cells in the desiccated state. Rehydrated unexpressed and AfrLEA3m 
expressed cells are those which were dry processed (spin-dried) and then immediately recovered 
to standard media conditions. The hyperspectral images were generated by integrating the CH2 
stretching region, and then individually normalized to the integrating peak, so that all images used 
a color scale of 0 to 1 a.u. Raman spectra obtained from area array scans and processed to subtract 
background and substrate spectra using WITec Project 4 software.  Further deconvolution analysis 
was conducted with Peakfit v4 software based on a 2nd derivative fitting algorithm (Systat 
Software, Inc., San Jose, CA), and Origin Pro 2018 (OriginLab, Northampton, MA). The higher 
wavenumber region from ~2700-3700 rel. 1/cm contains both CH2 stretching and OH stretching 
vibrational modes.  The following assignments in deconvolution analysis were made; CH2 




symmetric (3220 rel. 1/cm), OH asymmetric (3420 rel. 1/cm), and OH high (3590 rel. 1/cm).  
These last four represent OH stretching modes in descending order of H-bonding strength. A 
representative Raman spectrum of a control HepG2 cell in imaging solution, plotted with a 6-
component deconvolution, is shown in Fig. 5.9.     
 
5.2d Desiccation via Sessile Droplet 
Pure 42.5 mg/mL AfrLEA3 protein was dried in a 5 µL sessile droplet and monitored for 
moisture change. This was done by both gravimetry (Mettler Toledo  XP26, Columbus, OH) and 
by Raman spectroscopy. The droplet was deposited on a slide and intermittent weights were taken 
and recorded with respect to time.  After five measurements of no change, it was assumed to be 
maximally dried with respect to room conditions. The same droplet was deposited on a quartz slide 
for Raman acquisition.  The I3400:I2920 spectral ratio is representative of the total water amount 
(OH-stretching band) with respect to the protein concentration (CH2-stretching band). Spectral 
were collected after minor calibrations to account for shifting droplet dimensions.  Acquisition 
was concluded when steady spectra response was observed. 
Both HepG2 and transfected cells were grown, collected, and suspended with PBS in 
cryotubes to a concentration of 1x107 cells/mL. These were put through a freeze-thaw cycle five 
times (liquid nitrogen into 37°C water bath) to lyse the cells.  Lysates were pushed through 0.22 
µm syringe filters (Target2 PES, ThermoFisher) to remove cellular particulate. Lysate of both cell 
types were then scanned with Raman to determine sensitivity in determining characteristic 
differences between AfrLEA3m expressing cells and normal HepG2 cells, with a focus on 




A mitochondria extraction was performed on HepG2 cells using a microcentrifuge-based 
kit (Mitochondria Isolation Kit for Cultured Cells, ThermoFisher, Waltham, MA).  Briefly, 2x10^7 
cells were treated with kit reagents, homogenized, and then processed with several centrifugation 
steps between 700 x g and 12000 x g at 4°C.  The isolated mitochondria extract was used in the 
same manner as the cell lysates, both for drying and Raman acquisitions. 
These samples were mixed with pure 42.5 mg/mL AfrLEA3m protein at a 1:1 ratio. These 
were deposited on gold slides to be dried until in equilibrium with the environment, as shown in 
figure 5.11.  Raman acquisition of the sessile droplets were taken before and after drying.  The 
spectra were compared by taking the ratio of the 1320 rel. 1/cm peak, representing amide III 
secondary structure here α-helical groups and the 2920 rel. 1/cm peak, representing the CH2 
stretching band.  This indicates the relative amount of secondary structure with respect to the 
concentration of overall protein, on a spectroscopic basis.   
 
5.2e Bioenergetic Evaluation 
Analysis of metabolic function were carried out on an extracellular flux analyzer (XFp 
Seahorse, Agilent Technologies, Santa Clara, CA).  Cells were seeded in microwell plates at a 
seeding density of 2x104 cells per well. Both oxygen consumption rate (OCR) (representing 
mitochondrial respiration) and extracellular acidification rate (ECAR) (representing glycolysis) 
measurements were obtained. Briefly, XFp cartridge sensors were hydrated and injection ports 
were loaded with oligomycin (1 µM), carbonyl-cyanide-4-(trifluoromethoxy) phenylhydrazone 
(FCCP, 0.5 µM), and rotenone/antimycin A (0.5 µM).  Reagents used for glycolysis testing were 
D-glucose (10 mM), oligomycin (1 µM), and 2-deoxyglucose (2-DG, 50 mM).   Oligomycin was 




acts as an uncoupling agent that collapses the mitochondrial proton gradient and thereby uncouples 
oxidation from phosphorylation, maximizing oxygen consumption rates. The contribution to OCR 
via non-mitochondrial processes was quantified using rotenone and antimycin A, which inhibit 
complex I and III of the respiratory system, respectively.  Glucose was supplied as to fully saturate 
basal ECAR.  Oligomycin is injected to inhibit ATP synthase, arresting ATP production via 
oxidative phosphorylation, which then induces the cells to respond by increasing glycolysis to 
maximum levels, resulting in higher ECAR.  2-DG is a glucose analog which competitively 
inhibits hexokinase, effectively stopping glycolysis. 
 
5.3 Results 
The protein fingerprint region in Raman spectroscopy, containing significant amide peaks 
located at approximately 1200-1800 rel. 1/cm, yields the majority of cellular information and so 
is given particular attention. In Fig. 5.1A, the amide I group is shown located at ~1650 rel. 1/cm.  
Amide II is located at ~1450 rel. 1/cm while Amide III is located at ~1320 rel. 1/cm.  Raman 
spectroscopy presents the ability to view hyperspectral information with spatial definition. This is 
employed in Fig. 5.1B1-B4 to distinguish three cellular compartments of interest: total average 
cell, mitochondria, and membrane, with a corresponding merged image.  Each of these has an 





Figure 5.1: Representative Raman spectra of a hepatocellular carcinoma cell - A1) Hyperspectral 
Raman image of live hepatocellular carcinoma cell in culture conditions. The images were created 
using component analysis and by integrating spectral signatures collected from intracellular space. 
Figures A2 and A3 indicate distribution of mitochondrial and cellular membrane. Fig. A4 represent 
the composite image created by merging spectral signatures from A1-3.  The color mapped spectra 




HepG2 AfrLEA3m expressing cells were compared with non-expressing cells and the 
spectra for both were normalized against their respective CH2 symmetric peaks for protein 
evaluation, shown in Fig.5. 2A.  Fig. 5.2B is the normalized amide peak values for both cell 
conditions, showing slightly increased relative protein amount in the AfrLEA3m expressed cells.  
Both HepG2 AfrLEA3m expressing cells and non-expressing cells were lysed as previously 
described and evaluated in the same manner as single cell scans (Fig. 5.2C).  Normalized protein 





Figure 5.2: Comparison of unexpressed and AfrLEA3m expressed HepG2 cells - A) Amide peaks 
contained in fingerprint region shown in cells expressing AfrLEA3m compared to control cells. 
for both cell conditions, normalized to the CH2-stretching peak (2940 rel. 1/cm). B) Enumeration 
of (A) showing higher relative concentration of protein in AfrLEA3m expressed cells. C) Cell 
lysate from both cell types was collected and scanned as a bulk solution.  There is a very high 




Figure 5.3 displays time dependent drying of sessile droplets containing pure AfrLEA3m 
protein at a concentration of 42.5 mg/mL.  Fig. 5.3A graph shows that the droplet has 
approximately 90% of water removed via evaporation over the course of 17 minutes. Fig. 5.3B 
similarly displays the loss of water via evaporation, but on a spectral basis.  Here, there is an 
approximate 95.5% reduction is intensity ratio of the I3400:I2920 peaks.  The two methods combined 
provides for a means to compare the spectral ratio to standard residual moisture content on a mass 
basis.  The gravimetric apparatus is more tightly enclosed against the ambient than the Raman 





Figure 5.3: Drying of pure AfrLEA3m protein - A) Weight obtained via gravimetry of a droplet of 
42.5 mg/mL purified AfrLEA3 protein. B) The I3400:I2920 spectral ratio signifies the water content 
relative to the amount of protein in the analyte.  The same volume of droplet as used in gravimetric 
analysis was used for the spectral technique as well. A similar trend is shown for water content for 





HepG2 cell lysate and isolated mitochondria suspension was collected as described in 
methods.  Fig. 5.4A displays the spectral change in relative α-helical structure of cell lysate with 
and without being mixed pure AfrLEA3m protein. There was a decrease in I1320:I2920 ratio for the 
cell lysate upon drying, explained mostly by the artifact of the 2920 rel. 1/cm peak increasing 
concentration with drying. The I1320:I2920 ratio increases when the lysate is spiked with the pure 
protein.  For the isolated mitochondria (Fig. 5.4B), there is a small increase in I1320:I2920 ratio upon 
drying.  There is a much stronger increase for the mitochondria lysate when protein solution was 
included.  Figure 5.4C represents the change in drying performance upon addition of pure protein 
solution between the cell lysate and the isolated mitochondria, on an absolute basis. The 
distinguishing difference between the sample groups would be the difference in total lysate against 
the mitochondria extraction.  This is supported by that both solutions with AfrLEA3m protein 





Figure 5.4: Impact of AfrLEA3m upon desiccation characteristics of droplet dried cell and 
mitochondrial lysates - A) Comparison of the difference ratio for amide III group with spectral 
center at 1320 rel. 1/cm, indicating secondary structure, here α-helical groups, and the 2920 rel. 
1/cm CH2 stretching band from aqueous to desiccated form. This ratio is shown for both pure cell 
lysate and lysate which has been mixed with pure AfrLEA3m protein.  B) The same ratio as in (A) 
was taken but for isolated mitochondrial that was processed into lysate.  For both cellular lysate 
and mitochondrial lysate, an increase in ratio was much greater upon drying when containing 
AfrLEA3m. C) The relative difference between the impact AfrLEA3m has upon both cell lysate and 




Hyperspectral maps were generated for unexpressed and AfrLEA3m expressed cells in the 
desiccated state (Fig. 5.5).  The 755 rel. 1/cm peak corresponding to cytochrome c and 1308 rel. 
1/cm peak corresponding to α-helix protein structure were used for integration and intensity 
mapping.  For each cell type, a representative single cell scan was used to show co-localization 
between molecules of interest. A white dotted outline shows the actual cell membrane as viewed 
by polarized light microscopy. The results show highly correlated α-helix (Fig. 5.5A, B) and 
cytochrome c (Fig. 5.5C, D) regions.  The intensity for both cytochrome c and α-helix regions are 







Figure 5.5:  Hyperspectral image correlation of α-helix structure in desiccated environment - 
Raman hyperspectral images were integrated on the 755 rel.1/cm cytochrome c peak (red) and the 
1308 rel. 1/cm α-helical peak (blue), with composite merge shown. The images shown were 
acquired in desiccated state for control (HepG2), and stably transfected AfrLEA3 HepG2 cells 
with and without doxycycline inducement. There is much higher degree of α-helical structure 
directly correlated to cytochrome c signature in AfrLEA3 expressed cells over others. Outlines of 




Subcellular components were evaluated employing Raman spectroscopy.  The cellular 
membrane was given attention due to strong relation to desiccation injury. (Solocinski, 2018) Figs. 
5.5A and 5.5B show the cellular membrane mask generated by hierarchal cluster analysis which 
accords to the cells shown in Fig. 5.5 rehydrated cells for unexpressed and AfrLEA3m expressed 
conditions, respectively.  Fig. 5.5C shows the protein evaluation for the membrane.  The is no 
difference between amide I and III spectral regions.  However, there is an increased normalized 
amide II intensity for unexpressed cells compared with AfrLEA3m expressed cells.  Fig. 5.5D 
takes consideration of the mitochondrial regions, by considering cytochrome c peak (1127 rel. 
1/cm) in the Raman hyperspectral arrays.  This was taken as a ratio to the mitochondrial poise 
from the bioenergetic data to yield a spectrometabolic appraisal between the two cell conditions.  
There is a significant difference, with the cytochrome c/mitochondrial poise ratio being higher for 
AfrLEA3m expressed cells.   
From the hyperspectral maps in Fig. 5.3, averaged spectra were extracted and compared.  
Fig. 5.4A shows these spectra with the two previous peaks of interest annotated, for the 755 rel. 
1/cm and the 1308 rel. 1/cm. The increased cytochrome c peak indicates increased mitochondria 
for the cell.  Fig. 5.4B displays the normalized α-helix intensity to total organic content. The α-
helix peak intensity is only present in the AfrLEA3 expressed cells.  This is evidence for the 
increase in AfrLEA3 conformational shift from disordered to α-helix structure upon entering the 






Figure 5.6: Raman evaluation of α-helix structure for AfrLEA3m - A) Averaged spectra acquired 
from hyperspectral images of the three cell conditions.  There are several notable differences in 
spectra, notably the α-helix peak at 1308 rel. 1/cm.  B) Intensity of 1308 rel. 1/cm peak 
normalized to 2940 rel. 1/cm CH2 stretching peaks. AfrLEA3 expressing cells display a 
significantly higher degree of secondary protein conformation when induced via drying 




For the non-transfected cells, AfrLEA3m cells showed higher overall protein intensity than 
unexpressed cells.  This was independent of hydration level and also observed in the spin-dried 
cells. This was not the case with rehydrated cells where there were rather significantly decreased 
protein levels in AfrLEA3m cells. The dramatic shift in normalized protein concentrations in the 
spin-dried cells was expected; amide I contributions all but disappear as they are strongly related 
to water interactions.  The increased amide III intensity of the AfrLEA3m cells over unexpressed 
are also expected as the AfrLEA3m proteins becomes more structured (α-helix, β-sheet) upon acute 
desiccation.  
Fig. 5.7 displays bioenergetic data acquired from extracellular flux analysis and derived 
metabolic parameters.  Control and AfrLEA3m cells were compared before and after spin drying 
3 days after rehydration.  No difference for basal respiration among unprocessed cells and non-
transfected spin-dried cells was observed.  There was a significantly higher basal rate for spin dried 
AfrLEA3m cells.  Upon oligomycin injection, cells had a predictable drop in OCR, by about 
27.1%. FCCP increased OCR to maximum, to 122.1% of basal. Acute rotenone and antimycin A 







Figure 5.7: Bioenergetic outcomes and metabolic parameters - Results of the extracellular flux 
analysis of unprocessed and rehydrated conditions for both unexpressed and AfrLEA3m expressed 
cells. Metabolic analysis indicates desiccated and rehydrated AfrLEA3 expressed cells are 
comparable to unprocessed cells, whereas unexpressed cells have metabolic deficiencies. 
 
Fig. 5.7A displays post processing outcomes for HepG2, unexpressed AfrLEA3m cells, 
and expressed AfrLEA3m cells.  The two former samples had no immediate survival following 
spin drying treatment.  The LEA3 expressed cells had a 92.3% immediate viability, as measured 
by membrane integrity.  Fig. 5.8B displays growth for these treatment groups over a period of 7 




28-fold increase in cell number.  The desiccated HepG2 and unexpressed AfrLEA3m cells had no 
immediate viability and thus had corresponding zero growth.  The expressed AfrLEA3m cells had 
only 1.7-fold increase in cell number, only 6.1% of the unprocessed HepG2 cells.  This would 
seem to indicate that while AfrLEA3m conferred protection in the immediate sense, the cells still 
sustained injury in some other way. 
 
 
Figure 5.8: Viability of AfrLEA3m following desiccation - A) Percent survival, as measured by 
membrane integrity before dry processing and immediately after, for control HepG2 cells and 
HepG2 cells which have AfrLEA3 transfection, with (expressed) and without (unexpressed) 
doxycycline induction.  Only cells which had AfrLEA3 inducement had any survival, with very 
good recovery at near 97%.  B) Seven-day growth for HepG2 cells which were; control in 
physiological state (never dried), dried control cells, dried AfrLEA3 unexpressed cells, and dried 
AfrLEA3 expressed cells. Control cells not subjected to drying had a near 30-fold increase in cell 
number over 7 days.  Dried control and unexpressed AfrLEA3 cells had no survival and no growth. 







The potential of LEA group proteins for stabilization of biomedically relevant cells and 
tissues is well recognized, especially due to their prevalence in a diverse group of organisms which 
indicates broad protective mechanisms that are not cell or tissue type specific.  Previously, it has 
been demonstrated that during acute desiccation events, e.g., spin drying, cells expressing 
AfrLEA3m have significantly improved survival rates compared to non-transgenic control cells.  
It was the objective of this study to present an analytical method for characterizing the protective 
benefits of AfrLEA3m during water stress in HepG2 cells.   
From the data acquired from the hyperspectral scans (Fig. 5.3), several interesting 
differences are found between control cells and cells expressing AfrLEA3m.  Both, fully hydrated 
and desiccated AfrLEA3m cells had significantly higher total protein contents than non-transfected 
control concentrations.  The shift in amide intensities from the hydrated to the dry state carried an 
expected result, namely that the amide I signature were much decreased and amide III signatures 
showed strong increases.  There was a significant increase in amide III levels of AfrLEA3m 
expressed cells over unexpressed cells, which was expected as the intrinsically disorder protein 
would display an increase in secondary structures upon desiccation.  There is a distinct increase in 
amide II and III levels in the control HepG2 cells after desiccation and rehydration.  This may be 
due to a lower concentration of CH2 components, making the normalized intensities appear larger.  
This has been observed previously and could indicate cellular damage. The AfrLEA3m expressing 
cells show amide levels closer to hydrated control cells.  This lends support to the hypothesis that 
AfrLEA3m plays a protective role in desiccation events. 
Extracellular flux analysis shows an apparent increase in mitochondrial poise of processed 




balance of mitochondrial output relative to maximum potential) compared to never dried control 
cells.  There was an almost equivalent decrease in glycolytic poise for the same groups.  This may 
be explained by Warburg effect related metabolism of the HepG2 cell line.  After processing, acute 
energy demands of the cells may have been triggered and so mitochondrial activity was increased, 
with a proportional drop in normal glycolytic energy generation. 
The normalized Raman amide II spectral ratios according to the cellular membrane show 
significantly higher values for AfrLEA3m expressed cells over unexpressed cells.  This is most 
likely explained by residual increase of protein content.  
The cytochrome c/mitochondrial poise parameter assists in providing a description of 
metabolic efficiency by coupling bioenergetic and spectroscopic data.  AfrLEA3m expressed cells 
had a significantly lower ratio to that of unexpressed cells.  This can describe that there is less 
cytochrome c in the cellular composition as derived from the Raman spectra with respect to the 
mitochondrial poise.  A reasonable inference would be that the cells are therefore producing energy 
more efficiently, as for similar levels of metabolic output, there is less overall mitochondrial 
content, i.e., better efficiency.  It should be noted that the cytochrome c peak used (1127 rel. 1/cm) 
was fairly weak, having a STN ratio of only ~3 and so future analysis will try to focus upon 
increasing STN for our target analyte.  That stated, the spectrometabolic parameter establishes 
further support that cells which had protective AfrLEA3m protein, have better metabolic outcomes 
than cells which did not. 
This study intended to provide evaluation of AfrLEA3m protective abilities in mammalian 
cells. Raman spectroscopy offers a powerful tool to aide in providing intrinsic chemical cellular 




within gives strong further support that using LEA-group proteins as a dry preservation strategy is 
eminently viable, particularly when coupled with existing complementary techniques.  
 
 
Figure 5.9: 6-peak Deconvolution of CH2- and OH- Stretching Bands - The CH2-stretching mode 
was deconvoluted into two primary bands, denoted as symmetric (red) and asymmetric (pink).  
The OH-stretching band was deconvoluted into 4 primary peaks, denoted as low (yellow), 
symmetric (green), asymmetric (blue), and high (orange).  The black line is the convolution of 












Figure 5.11: Dried droplets of cell and isolated mitochondrial lysates, with and without AfrLEA3m 
pure protein addition - 5 µL droplets were allowed to dry in sessile fashion on gold plates.  Images 






Chapter 6  
Spectrometabolic Response to Galactose Treatment 
 
6.1 Introduction 
A totalistic characterization methodology was undertaken for the metabolic response to 
replacement of glucose medium with an alternative hexose source, galactose.  (Skolik, 2021) One 
key facet of the multi-level analysis technique is the spectrometabolic method described in the 
following. 
An identic difference between primary cells and tumor derived cells is a metabolic 
proclivity towards lactate production in the latter.  This can largely be attributed to a shift from 
mitochondrial oxidative phosphorylation to substrate level phosphorylation. (Warburg, 1956) It 
was originally thought that lower rates of respiration were due to mitochondrial dysfunction, but 
that has been shown to not necessarily be the case as many cancer cell lines have completely 
functional mitochondria. (Warburg, 1956; Moreno-Sanchez, 2007) From recent literature, it would 
seem it is not ATP, but biosynthetic precursors which control proliferation rates in tumor-origin 
cells. (Vander Heiden, 2009) An increase in glycolytic flux has corresponding increase in linked 
biosynthetic pathways. (Lunt, 2011; DeBeradinis, 2008) As an example, the pentose phosphate 
pathway has genesis in the glycolysis intermediate metabolite glucose-6-phosphate, which sees 
elevated activity in tumor origin cells. The pentose phosphate pathway in turn creates biosynthetic 
precursors, e.g., NADPH, for functions including lipid synthesis and maintenance of redox 




origin cells and primary cells are often not considered. It is shown in the following that replacement 
of primary hexose source from glucose to galactose reintroduces a metabolic modality to cancerous 
cells which is more akin to their primary cell counterparts. This has the obvious implication of 
improving the physiological relevance for tumor origin cells in biomedical research.  It also carries 
with it the potential for insights into therapeutics targeting cancers specifically due to their 
metabolic poise. 
It has been shown that for certain immortalized cell lines, a metabolic shift favoring 
oxidative phosphorylation occurs when switching form glucose to galactose. (Rossignol, 2004) An 
increase in oxygen consumption at the mitochondria, along with decreased lactate production 
indicates this substrate shift decreases glycolytic flux while increasing ATP production in the 
mitochondria. (Gohil, 2010; Grimm, 2017) There is also proof that cells incubated with galactose 
replacement have increased production of proteins necessary for oxidative phosphorylation as well 
as being more susceptible to mitochondria dysfunction and toxins. (Marroquin, 2007; Arroyo, 
2016; Bayona-Bafaluy, 2011) Overall, the effects of galactose incubation to tumor derived cells 
have been insufficiently characterized. 
Both glucose and galactose are converted to glucose-6-phosphate after uptake into the cell 
by means of solute carrier 2A proteins or sodium dependent hexose transporters. (Augustin 2018; 
Ghezzi, 2018; Tahrani, 2013) However, glucose accomplishes this in a single enzymatic step while 
galactose requires four reactions of the Leloir pathway. (Holden, 2013) ATP production via 
catabolism of either sugar has similar potential yields, and both produce glucose-6-phosphate 
which can be utilized in glycolysis or the pentose phosphate pathway. (Frey, 1996) 
Herein, the physiological effects of galactose replacement on tumor derived cell lines are 




to their high metabolic plasticity and widespread use in hepatoxicity assessment. (Soldatow, 2013; 
Tolosa, 2013) It is shown herein that galactose replacement decreases both mitochondrial and 
cytosolic NAD+/NADH ratios against cells maintained in glucose culture.  This is suggestive that 
such a substrate replacement could normalize HepG2 metabolism to a more typically found 
primary hepatocyte metabolic poise, in order to increase physiological relevancy in biomedical 
research utilizing these cells for biomedical application. 
 
6.2 Materials and Methods 
 
6.2a Chemicals 
Chemicals acquired for solution preparations were of the highest purity and purchased 
either from Sigma-Aldrich (St. Louis, MO) or Thermo Fischer Scientific (Waltham, MA). 
Reagents for extracellular flux analysis were acquired from Seahorse Bioscience (Billerica, MA). 
 
6.2b Cell Culture 
Human hepatocellular carcinoma cells (HepG2) were purchased from the American Type 
Culture Collection (ATCC, Manassas, VA) and cultured in T-75 flasks (Corning Company, 
Corning, NY). Cells were grown in media composed of glucose-free Dulbecco’s modified eagles 
medium (DMEM) (Thermo Fischer Scientific, Waltham, MA) supplemented with 2 mM glutamine 
(VWR, West Chester, PA), 1 mM pyruvate (Corning Company, Corning, NY), 10 mM glucose 
(Thermo Fischer Scientific, Waltham, MA), and 10% dialyzed fetal bovine serum (12-14 kDa) 
(Atlanta Biologicals Inc., Flowery Branch, GA). Depending on experimental group, either 10 mM 




(galactose medium) or non-dialyzed FBS (Atlanta Biologicals Inc., Flowery Branch, GA) was 
substituted for dialyzed FBS to culture cells. All cells were maintained in a humidified atmosphere 
at 5% CO2 and 95% air at 37°C. Culture medium was renewed every two days and cells were 
passaged before reaching 90% confluency. To subculture, cells were dissociated from the culture 
flasks using 0.25% trypsin and 1 mM EDTA in a balanced salt solution (Thermo Fischer Scientific, 
Waltham, MA), centrifuged at 200 x g for 5 min. 
 
6.2c Extracellular Acidification Rates 
To characterize extracellular acidification rates (ECAR) of HepG2 cells, an XFp Seahorse 
flux analyzer (Agilent Technologies, Santa Clara, CA) was used. The day prior to ECAR 
measurements, cells were placed into glucose-containing medium in standard microwell plates at 
a seeding density of 2 x 104 cells per well. ECAR measurements were collected using the Seahorse 
standard protocol and cartridge sensors were hydrated with XF calibrant overnight. On the day of 
the experiment, medium was aspirated and replaced with the experimental medium. Cells were 
contained in an incubator with hydrated air at 37°C for 1 hr for CO2 gas removal. Following 
incubation, ten measurements were taken in three minute intervals. The lactate dehydrogenase 
inhibitor GSK 2837808A (Torcis, Bristol, United Kingdom) was used at a final injection 
concentration of 20 μM. The plate was mixed and analyzed before and after injections to obtain 





6.2d Raman Microspectroscopy 
HepG2 cells were grown for 4 weeks either in glucose or galactose medium before 
conducting Raman microspectroscopic experiments. Spatially correlated Raman 
microspectroscopic measurements were acquired using a customized confocal microscope (Zeiss 
Corp., Oberkochen, Germany) and Raman spectrometer combination (UHTS 300, WITec 
Instruments Corp., Ulm, Germany) connected to a CCD camera (Andor Technology, Belfast, 
Ireland). A 532 nm solid-state laser calibrated to 20 mW was used for excitation and a custom 50X 
objective for observation (Mitutoyo, Sakado Japan). The changes in the spectral signature from 
the intracellular space were analyzed using a hyperspectral molecular analysis technique. Spectral 
arrays were collected using a spatial dimension of 30 μm × 30 μm with a spectral dimension of 90 
x 90 pixels (n = 3). Each array of scans was collected using an integration time of 0.5 s. Typical 
background and substrate subtractions were employed, using WITec Project 5 and Peakfit v4 
software. Principal component analysis (PCA) was used to reduce the dimensionality of the 
collected spectral data arrays into principal components (PCs) and then reconstructed according to 
a signal-to-noise threshold for selecting PC number. Following noise reduction using PCA, 
hierarchal cluster analysis was used to construct average spectral signatures for regional 
components of the cellular hyperspectral arrays based on significant components. Brightfield 
images were taken to locate desired cells. Following acquisition of hyperspectral Raman array 
scans, a cluster analysis was performed to yield discreet binned spectral groups.  Each cluster 
produces an averaged Raman spectrum (755 rel. 1/cm is assigned to cytochrome-c, 1012 rel. 1/cm 
is assigned to NAD+, 1594 rel. 1/cm is assigned to NADH, and the wide band centered at 2940 rel. 




assignment for NAD+, NADH, and cytochrome c mentioned here were verified by collection of 
spectral signatures from pure reagents, respectively.  
 
6.2e Statistical Analysis 
Data was analyzed using an unpaired two-tailed t-test, or one-way analysis of variance 
(ANOVA) test.  Statistical analysis was evaluated using GraphPad Prism 8.4 software (GraphPad 
Software Inc., San Diego, CA).  
 
6.3 Results 
Metabolomic analysis reveals a statistically insignificant trend towards a lower NAD+/ 
NADH redox ratio in cultured cells which have undergone galactose replacement. However, these 
bulk measurements do not allow for acquisition of subcellular resolution and so the Raman 
spectrometabolic technique was developed to characterize single cell redox ratios. The 
compartment specific measurements are initialized by first scanning pure NAD compounds. Then 
identification of these signatures in single aqueous HepG2 cells through confocal Raman 
microspectroscopy to independently monitor the mitochondrial and cytoplasmic NAD+/NADH 
redox ratios (Fig. 6.1A-C) was established. Cytochrome-c was used as the signature to identify 
mitochondrial regions, calculate the average spectra for these regions, and ultimately allow for 
comparisons to be made between the redox ratios measured in both the mitochondrial and 
cytoplasmic compartments. The technique accuracy was tested by introduction of the lactate 
dehydrogenase inhibitor, GSK 2837808A (20 µM), in order to prevent oxidation of NADH to 
NAD+ in the cytosolic environment while at the same time extracellular acidification rates (ECAR) 




a 169 ± 8.2% lower ECAR compared to the glucose control. LDH inhibition significantly lowered 
ECAR in glucose by 145 ± 10% and by 37 ± 8% for galactose cultured cells and resulted in a 
comparative 51 ± 10% difference of ECAR in the presence of the LDH inhibitor (Fig. 6.1D).  
Raman microspectroscopy measured the cytoplasmic NAD+/ NADH redox ratio for HepG2 cells 
cultured with galactose was 26 ± 6% lower in absence of the LDH inhibitor (Fig. 6.1E). After LDH 
inhibition, the cytoplasmic NAD+/NADH redox ratio decreased by 43 ± 7% in glucose and 32 ± 
4% in galactose cultured cells. Despite the redox ratios decreasing for both glucose and galactose 
conditions upon injection of the LDH inhibitor, a significantly lower redox ratio was shown for 
galactose treated cells compared to glucose cultured cells. As aforementioned, the mitochondrial 
NAD+/NADH ratio was assessed in both glucose and galactose substituted cells via colocalization 
with the cytochrome-c signature. The mitochondrial redox ratio was lower for both conditions 
when compared to the cytoplasmic redox ratios. Cells cultured with galactose were shown to have 







Figure 6.1:  Galactose shifts cytoplasmic NAD(H) redox ratio - Acquisition of Raman spectra of 
pure NAD+, NADH, NADP+, and NADPH compounds and identification in HepG2 cells. The 
fingerprint region of each of each of the compounds were used to spatially correlated with the 
intracellular distribution of the compounds.  A) Representative Raman spectra of a cluster average. 
B) Intensity of 755 rel. 1/cm peak, representing cytochrome C, increasing as function of cluster 
degree. C) Cascade graph of Raman spectra for four related NAD compounds. D) Extracellular 
acidification of HepG2 cells cultured with glucose or galactose in presence or absence of the LDH 
inhibitor, GSK 2837808A (20 µM). #Indicates statistically significant differences compared to 
glucose control. *Indicates statistically significant between glucose and galactose condition in 
presence of LDH inhibitor (One-way ANOVA, p < 0.05, n = 8, average ± SEM). E) Cytoplasmic 
NAD+/NADH ratio obtained from Raman spectra for HepG2 cells cultured with glucose or 
galactose in presence or absence of GSK 2837808A (20 µM). #Indicates statistically significant 
differences compared to glucose control. *Indicates statistically significant between glucose and 
galactose condition in presence of LDH inhibitor. (One-way ANOVA, p < 0.05, n = 6, average ± 
SEM). F) Mitochondrial NAD+/NADH obtained from Raman spectra for HepG2 cells cultured in 
glucose or galactose. #Indicates statistically significant differences compared to glucose control. 






Here it is demonstrated that it is possible to shift the metabolic poise of tumor origin HepG2 
cells to more closely mirror their primary hepatocyte counterparts via the replacement of glucose 
with galactose substrate source.  While there have been some studies done into the increased 
oxidative phosphorylation activities of galactose incubated cells, the overall implications for 
global metabolic pathways has been insufficiently explored. (Aguer, 2011; Dott, 2014) Therefore, 
to investigate the subcellular localized involvement of the redox state to overall metabolic poise, 
the Raman spectrometabolic technique was used to evaluate the compartmentalized NAD+/NADH 
ratios. This characterization technique allowed for effective differentiation of impact on global 
metabolic pathways based on the hexose source used.  
Admittedly, galactose replacement as a technique to shift respiration profiles to more close 
match primary cells may only be limited to specific cell lines, such as the HepG2s evaluated here.  
It is thought that galactose serves as a necessary substrate source in a glucose free environment. 
While glycolysis pathways produce equal ATP yields for both glucose and galactose, it has been 
posited that galactose cultured cells likely derive most ATP form catabolism of glutamine and 
pyruvate. (Reitzer, 1979) It is hypothesized that galactose is a critical carbon contributor to the 
pentose phosphate pathway, which is also surmised to likely be the primary metabolic pathway for 
cells cultured in a galactose medium, over the TCA cycle. 
The NAD+/NADH ratio can be used as a prime metric for metabolic appraisal.  The 
NAD+/NADH ratio is responsible for the regulation of flux through many different metabolic 
pathways. (Hosios, 2018) It has been thought that high NAD+/NADH ratios will typically facilitate 
cell proliferation through flux sustainment via oxidative biosynthetic pathways. (Diehl, 2019; Gui, 




techniques is that it can only evaluate total NAD compound levels.  However, NAD concentration, 
NAD synthesis, and the overall redox ratios vary drastically with subcellular localization. 
(Cambronne, 2016) As an example, NAD levels in the mitochondria are largely unaffected by the 
depletion of NAD compounds in the cytoplasm, and NAD concentration are somewhere between 
two and tenfold greater in the mitochondria. (Alano, 2007; Pittelli, 2010; Tischler, 1977; Yang, 
2007)  Also, NAD+/NADH ratios in the mitochondria can range anywhere from 2 – 8, while the 
redox ratio occurring in the cytoplasm ranges from 0.1 – 600. (Lin, 2003; Sun, 2012; Williamson, 
1967) 
Employing the Raman spectroscopy, localized spectrometabolic analysis was able to be 
carried out.  It was observed that there was lower NAD+/NADH ratios in the mitochondria, 
compared to the cytoplasm for the HepG2 model system investigated, for both glucose and 
galactose treatment groups.  However, the cells which had galactose replaced culture conditions 
had a lower NAD+/NADH ratio for both mitochondrial and cytoplasmic regions.  So, the shift in 
metabolic poise occurs across the entirety of the cell upon replacement of glucose with galactose.   
The NAD+/NADH ratio in the cytoplasm is regulated primarily by the conversion of pyruvate to 
lactate via lactate dehydrogenase.  This lactate dehydrogenase reaction is about twice as fast than 
general flux rates via glycolysis, which results in fast regeneration of NAD+ when pyruvate 
concentrations are high. (Sun, 2012) An increased metabolic flux via lactate dehydrogenase is seen 
in glucose conditioned HepG2 cells over those which had only galactose incubation, resulting in 
higher NAD+/NADH ratios in the cytoplasm.  An increase in NAD+ bioavailability might allow 
for sustained glycolytically linked ATP generation, as well as facilitating metabolic flux for 




metabolic shift which corresponds to altering hexose source from glucose to galactose in HepG2 
cells may lower overall compartmentalized NAD+/NADH ratios.  
This study presents a highly utilizable technique in spectrometabolic characterization.  The 
utility shown here was to evaluate the substitution of hexose source to better reflect the metabolic 
modalities of primary hepatocytes.  Leveraging the microspectroscopic features of the analysis, 
redox ratios were able to be quantified for independent intracellular compartments, notably the 
mitochondria and the cytoplasm. Such analysis regimes can be used to explore cancer remediation 




Chapter 7  
Future Research and Conclusion 
 
The research contained in the previous pages serves as the stage for a technique which has 
amazing potential for great public health benefits.  The standard premise of the technique is such; 
begin by characterizing the bioenergetics of model mammalian cells using standard metabolic 
profiling.  Then, implement Raman microspectroscopic global analysis to elucidate all internal 
biochemical signatures quantitatively. Then, create the bridging analysis method to connect the 
spectroscopic data towards the standardized metabolic data. Use this spectrometabolic analysis 
technique as a framework to then evolve into more advanced, optimal techniques.  Finally, test 
this model in a diagnostic, if not clinical, role to validate novel technique efficacy.  This is the 
hopeful proposed course for the methods which have been initially tested herein. 
Going forward, a key technique towards optimization that has seen exponentially increased 
use is that of big data, in neural networks/artificial intelligence.  Computing power is becoming 
increasingly cheap and common, and strategies for leveraging computer analysis of monstrous 
amounts of data is becoming a standardized notion.  This is highly relevant to the works completed 
and to the future path proposed.  For the type of information that Raman microspectroscopy 
provides, particularly with hyperspectral chemical imaging, it is well suited for the setting of a 
neural network.  The layers of information that spectroscopy is entwined with may seem 
burdensome when dealing with it case by case, but eventually it can be imagined to be an immense 




drawn, fed into a spectroscopic analyzer, the raw data from which enters a conditioned neural 
network system, and one of several analysis outcomes provided.  This can be seen as a yes/no 
operator for, “Is this sample cancer tissue?”.  Or for evaluating metabolic flux for prescreening 
neurodegenerative disorders. To this end, through this work, it has been demonstrated that 
spectroscopic insights into not only metabolic changes were made, but other compounding 
variables, in a unified analysis methodology.  This includes the effect of potential pharmaceutical 
candidates on not only the overall metabolism but also the compartmentalized subcellular 
structures in model adrenal gland cells. The implication of reactive oxygen species induced 
toxicity complicity was evident by multiple techniques, namely; microspectroscopy, standard 
growth studies, metabolic profiling, and reactive oxygen species quantification assays.  In the 
future, only the spectrometabolic technique would ideally be employed, saving valuable time and 
efforts. 
Another interesting topic evaluated was that this technique demonstrated that spectroscopy 
could illuminate the subcellular machinations of a protein conforming to a predetermined 
secondary structure to impart stability upon a desiccation event.  This is a biomimetic strategy 
taken from nature, who has carefully refined so many extraordinary techniques through the eons.  
However, humanity in its own cleverness has created the tools of CRISPR/Cas9 and other 
advanced gene editing tools to, with surgical precision, alter the possibilities of life.  With 
strategies such as imparting desiccation tolerance to animals, or even humans on the (likely distant) 
horizon, the need to have effective tools for equally precise analysis must be developed and 
refined.  The spectrometabolic techniques described can simultaneously examine the protein 
structure, metabolism, associated potential illnesses, and even more inherent features as research 




dynamics are often interlocked in effects and more univariate analysis forms can miss one while 
probing another.   
The days when one could master the knowledge of all life’s domains has long since passed.  
The level of speciality one must have to break through scientific boundaries is extraordinary.  The 
ironic feature of this condition is that so many of the most profound insights, inventions, and 
discoveries are had when non-associated areas of research are brought together in academic fusion.  
Furthermore, esoteric pursuits can be exceptionally interesting but relatively fruitless.  There must 
be a human component for meaning to be instilled.  And so, the proposed technique discussed 
previously is meant to be a bridge between several disciplines for the betterment of the human 
condition. There is a high hope that some meaningful fruits can be had from the research provided, 
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